Iveena Delivery Systems, Inc.
IVMED-80, a topical eye drop therapeutic that restores lysyl oxidase activity to strengthen corneal collagen and treat keratoconus
- Sector
- Medtech
- Headquarters
- Sandy, UT
- Founded
- 2014
- Latest Form D
- $2.5M offered, May 2019
- Total capital
- $6.6M
- Federal grants
- $6.6M
- 11 awards · 2014–2025
- Rank in peer group#12 of 41
- Private capital raised
- $10K
- 4 Form D · last May 2019
- 89 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 5 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Topical Eyedrops Increasing Lysyl Oxidase and Dopamine Activity to Control Myopia$934K
- Federal grantHealth and Human S · Phase I · Topical Eyedrops Increasing Lysyl Oxidase Activity to Control Myopia$345K
- Federal grantHealth and Human S · Phase II · Topical Eyedrop Therapy for Keratoconus$909K
- Federal grantHealth and Human S · Phase II · Topical Eyedrop Therapy for Keratoconus$1.7M
- Federal grantHealth and Human S · Phase II · Targeted Intraceptors for Macular Degeneration$1M
- Federal grantHealth and Human S · Phase II · Targeted Intraceptors for Macular Degeneration$458K
- Federal grantHealth and Human S · Phase II · Targeted Intraceptors for Macular Degeneration$544K
- Offering registeredForm D · SEC · 4th filing$2.5M
- Offering registeredForm D · SEC · 3rd filing$2.5M
- Offering registeredForm D · SEC · 2nd filing$1M
- Private capital raisedForm D · SEC · 1st filing$10K
Show 4 earlier federal awards
- Federal grantHealth and Human S · Phase I · Topical Eyedrop Therapy for Keratoconus$225K
- Federal grantNSF · Phase I · SBIR Phase I: Dual suppression of VEGF-A and PDGF-B with extended gene therapy for neovascular AMD$225K
- Federal grantHealth and Human S · Phase I · Targeted Intraceptor Nanoparticle for Macular Degeneration$25K
- Federal grantHealth and Human S · Phase I · Targeted Intraceptor Nanoparticle for Macular Degeneration$217K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
4months
from Iveena Delivery Systems, Inc.’s first federal award to its first private round.
- First federal award · Dec 2014
- Health and Human S · $217K
- First Form D · May 2015
- $10K · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 41 peers
Line = medianMedtech · Molecule
- Federal grants#12 · top 29%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Balamurali U AmbatiExecutive Officer, DirectorNamed in SEC Form D filings
- Barry HanoverDirectorNamed in SEC Form D filings
- David RobinsonDirectorNamed in SEC Form D filings
- Gerald SimmonsExecutive OfficerNamed in SEC Form D filings
- Greg JonesDirectorNamed in SEC Form D filings
- Heffernan U RonDirectorNamed in SEC Form D filings
Show all 10 people
- James JensenDirectorNamed in SEC Form D filings
- Jayakrishna U AmbatiDirectorNamed in SEC Form D filings
- Ned U WeinshenkerExecutive Officer, DirectorNamed in SEC Form D filings
- Robert U DempseyDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 5- PendingTreatment Of AstigmatismUSPTOApplication 18274647
- PendingTreatment Of AstigmatismUSPTOApplication PCTUS2022014198
- PendingTreatment Of AstigmatismUSPTOApplication 63144237
Show all 5 patent records
- Treatment Of AstigmatismMar 21, 2024 · Application 18274647Pending
- Treatment Of AstigmatismApplication PCTUS2022014198Pending
- Treatment Of AstigmatismApplication 63144237Pending
- Multi-agent Occular Formulations And Treatment MethodsApplication 62873121Pending
- Prevention Of Myopic ProgressionApplication 62614230Pending
Related companies, and why
- INVENTORS' WORKSHOPS, INC.Similar federal contract value in Medtech · null in contracts
- CLINITECH, LLCSimilar federal contract value in Medtech · null in contracts
- Innovative Biotherapies, Inc.Similar federal contract value in Medtech · null in contracts
- SafePath Medical, Inc.Similar federal contract value in Medtech · null in contracts
- ROPAmedics, LLCSimilar federal contract value in Medtech · null in contracts
- Universal Adherence LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .